Replies to post #190077 on Biotech Values

[DewDiligence]

MYL responds to buyout rumor:

http://finance.yahoo.com/news/mylan-comments-recent-media-speculation-184500701.html

We have studied the potential combination of Mylan and Teva for some time and we believe it is clear that such a combination is without sound industrial logic or cultural fit. Further, there would be significant overlap in the companies' businesses and we believe that it is unlikely that any such combination could obtain anti-trust regulatory clearances.

Of course, should any party make an actual offer to acquire Mylan, the Board would carefully consider it in exercising its fiduciary duties in the best interests of the company, our stockholders and other stakeholders.

Inclusion of the second paragraph above suggests that a buyout offer might actually be coming.